LLY

1,014.52

-3.15%↓

JNJ

243.43

-0.55%↓

ABBV

224.55

-3.14%↓

NVS

165.62

-1.16%↓

MRK

120.01

-3.14%↓

LLY

1,014.52

-3.15%↓

JNJ

243.43

-0.55%↓

ABBV

224.55

-3.14%↓

NVS

165.62

-1.16%↓

MRK

120.01

-3.14%↓

LLY

1,014.52

-3.15%↓

JNJ

243.43

-0.55%↓

ABBV

224.55

-3.14%↓

NVS

165.62

-1.16%↓

MRK

120.01

-3.14%↓

LLY

1,014.52

-3.15%↓

JNJ

243.43

-0.55%↓

ABBV

224.55

-3.14%↓

NVS

165.62

-1.16%↓

MRK

120.01

-3.14%↓

LLY

1,014.52

-3.15%↓

JNJ

243.43

-0.55%↓

ABBV

224.55

-3.14%↓

NVS

165.62

-1.16%↓

MRK

120.01

-3.14%↓

Начало・Списък с акции・Avita Therapeutics Inc

Avita Therapeutics Inc

Отворен

4.94 -2.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.85

Максимум

5.11

Ключови измерители
By Trading Economics
Приходи	1.6M -12M
Продажби	554K 18M
EPS	-0.536
Марж на печалбата	-65.968
Служители	226
EBITDA	1.6M -9.7M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	-16.51% downside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	25M 149M
Предишно отваряне	7.31
Предишно затваряне	4.94

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

8.83 / 9.77 Подкрепа & съпротива

Avita Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.02.2026 г., 23:25 ч. UTC

Горещи акции

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25.02.2026 г., 23:15 ч. UTC

Печалби

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25.02.2026 г., 23:54 ч. UTC

Пазарно говорене

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25.02.2026 г., 23:47 ч. UTC

Печалби

Ferrovial 4Q Net EUR197M >FER.MC

25.02.2026 г., 23:45 ч. UTC

Печалби

Ferrovial 4Q Rev EUR2.72B >FER.MC

25.02.2026 г., 23:42 ч. UTC

Печалби

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25.02.2026 г., 23:38 ч. UTC

Пазарно говорене

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com: Company's Business Operations Remain Normal >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25.02.2026 г., 23:25 ч. UTC

Печалби

Trip.com FY EPS CNY47.67 >TCOM

25.02.2026 г., 23:06 ч. UTC

Печалби

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25.02.2026 г., 23:01 ч. UTC

Печалби

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25.02.2026 г., 23:00 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

25.02.2026 г., 23:00 ч. UTC

Пазарно говорене

Печалби

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25.02.2026 г., 22:56 ч. UTC

Пазарно говорене

Печалби

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25.02.2026 г., 22:43 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25.02.2026 г., 22:40 ч. UTC

Пазарно говорене

Печалби

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25.02.2026 г., 22:40 ч. UTC

Печалби

Karoon Energy Says Search for New CFO Well Advanced

25.02.2026 г., 22:39 ч. UTC

Печалби

Karoon Energy Says CFO Ray Church to Leave Company

25.02.2026 г., 22:39 ч. UTC

Печалби

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25.02.2026 г., 22:38 ч. UTC

Печалби

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Сравнение с други в отрасъла

Ценова промяна

Avita Therapeutics Inc Прогноза

Ценова цел

By TipRanks

-16.51% надолу

12-месечна прогноза

Среден 4.5 USD -16.51%

Висок 5.5 USD

Нисък 3.5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Avita Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Avita Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

8.83 / 9.77Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.